TRUMF - Terumo Corporation (TRUMF) Q1 2022 Results - Earnings Call Transcript

Terumo Corporation (TRUMF) Q1 2022 Results Conference Call August 5, 2021 07:00 AM ET Company Participants Naoki Muto - CFO Presentation Naoki Muto I am the CFO, Muto. I will now explain the first quarter results for the fiscal year ending March 2022. First, the highlights from the quarter. Sales revenue was our highest ever for a quarter. In particular, a notable recovery of demand appeared in the Cardiac and Vascular Company, which had been greatly impacted by COVID-19. In FX, the dollar and euro both had a positive effect for Terumo. Adjusted operating profit was also the highest ever for a quarter. Along with the recovery in sales, improvement in product mix also pushed profitability upward. Negative impacts, including production adjustment and national tenders in China had their expected effects but expenses rose only gradually due to COVID-19. Taking into account these first quarter results, we are revising upward

For further details see:

Terumo Corporation (TRUMF) Q1 2022 Results - Earnings Call Transcript